Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

TELA Bio, Inc. (TELA)

Compare
1.0022
+0.0451
+(4.71%)
As of 9:43:50 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
69,300
69,300
58,453
41,418
29,463
Cost of Revenue
22,812
22,812
18,341
14,374
10,650
Gross Profit
46,488
46,488
40,112
27,044
18,813
Operating Expense
88,183
88,183
84,187
66,051
48,264
Operating Income
-41,695
-41,695
-44,075
-39,007
-29,451
Net Non Operating Interest Income Expense
-5,290
-5,290
-5,223
-4,051
-3,597
Other Income Expense
9,000
9,000
2,634
-1,238
-228
Pretax Income
-37,985
-37,985
-46,664
-44,296
-33,276
Tax Provision
-144
-144
--
--
--
Net Income Common Stockholders
-37,841
-37,841
-46,664
-44,296
-33,276
Diluted NI Available to Com Stockholders
-37,841
-37,841
-46,664
-44,296
-33,276
Basic EPS
-1.33
--
-2.04
-2.72
-2.30
Diluted EPS
-1.33
--
-2.04
-2.72
-2.30
Basic Average Shares
28,526.4410
--
22,868.6630
16,267.6780
14,473.2130
Diluted Average Shares
28,526.4410
--
22,868.6630
16,267.6780
14,473.2130
Total Operating Income as Reported
-34,115
-34,115
-44,075
-39,007
-29,451
Total Expenses
110,995
110,995
102,528
80,425
58,914
Net Income from Continuing & Discontinued Operation
-37,841
-37,841
-46,664
-44,296
-33,276
Normalized Income
-45,392.2644
-45,392.2644
-46,664
-43,068
-33,276
Interest Expense
5,290
5,290
5,223
4,051
3,597
Net Interest Income
-5,290
-5,290
-5,223
-4,051
-3,597
EBIT
-32,695
-32,695
-41,441
-40,245
-29,679
EBITDA
-31,683
-31,683
-40,633
-39,058
-29,144
Reconciled Cost of Revenue
22,812
22,812
18,341
14,374
10,650
Reconciled Depreciation
1,012
1,012
808
1,187
535
Net Income from Continuing Operation Net Minority Interest
-37,841
-37,841
-46,664
-44,296
-33,276
Total Unusual Items Excluding Goodwill
7,580
7,580
--
-1,228
--
Total Unusual Items
7,580
7,580
--
-1,228
--
Normalized EBITDA
-39,263
-39,263
-40,633
-37,830
-29,144
Tax Rate for Calcs
0
0
--
--
--
Tax Effect of Unusual Items
28.7356
28.7356
--
--
--
12/31/2021 - 11/8/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SGHT Sight Sciences, Inc.
2.5800
-1.15%
 
ELUT Elutia Inc.
2.1316
+1.50%
 
SIBN SI-BONE, Inc.
13.10
-1.73%
 
TLSI TriSalus Life Sciences, Inc.
5.60
-2.27%
 
BDMD Baird Medical Investment Holdings Limited
5.42
+3.24%
 
IART Integra LifeSciences Holdings Corporation
15.63
-0.74%
 
CATX Perspective Therapeutics, Inc.
1.8350
-0.81%
 
NSPR InspireMD, Inc.
2.5350
-2.50%
 
RXST RxSight, Inc.
14.49
-0.28%
 
ESTA Establishment Labs Holdings Inc.
30.74
+1.86%